[
  {
    "ts": "2026-02-04T03:18:51+00:00",
    "headline": "What To Expect From Cardinal Health’s (CAH) Q4 Earnings",
    "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be reporting results this Thursday before the bell. Here’s what to expect.",
    "url": "https://finance.yahoo.com/news/expect-cardinal-health-cah-q4-031851240.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "08d30ec1-53ab-397c-b864-e4915baba09b",
      "content": {
        "id": "08d30ec1-53ab-397c-b864-e4915baba09b",
        "contentType": "STORY",
        "title": "What To Expect From Cardinal Health’s (CAH) Q4 Earnings",
        "description": "",
        "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be reporting results this Thursday before the bell. Here’s what to expect.",
        "pubDate": "2026-02-04T03:18:51Z",
        "displayTime": "2026-02-04T03:18:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/5f4556e7db3b03584f5317169632a051",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CAH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l0YsFj0AItVPEFHqysfxuw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/5f4556e7db3b03584f5317169632a051.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/17e7HyzcCmNMNPrktKvduQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/5f4556e7db3b03584f5317169632a051.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/expect-cardinal-health-cah-q4-031851240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-cardinal-health-cah-q4-031851240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T13:47:00+00:00",
    "headline": "Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?",
    "summary": "CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.",
    "url": "https://finance.yahoo.com/news/pharmacy-consumer-wellness-segment-lead-134700112.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "77baf1e1-51cd-363a-bbc9-f0f7b182a440",
      "content": {
        "id": "77baf1e1-51cd-363a-bbc9-f0f7b182a440",
        "contentType": "STORY",
        "title": "Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?",
        "description": "",
        "summary": "CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.",
        "pubDate": "2026-02-04T13:47:00Z",
        "displayTime": "2026-02-04T13:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharmacy-consumer-wellness-segment-lead-134700112.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharmacy-consumer-wellness-segment-lead-134700112.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T15:23:00+00:00",
    "headline": "Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect",
    "summary": "EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-deck-152300057.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e9468caa-e2d0-3c65-9391-360888f55bc3",
      "content": {
        "id": "e9468caa-e2d0-3c65-9391-360888f55bc3",
        "contentType": "STORY",
        "title": "Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect",
        "description": "",
        "summary": "EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.",
        "pubDate": "2026-02-04T15:23:00Z",
        "displayTime": "2026-02-04T15:23:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4bb8b31b056b56472902a0ddb5b53e3d",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yLj2Kq0hqp9.ztSIpA4rHA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4bb8b31b056b56472902a0ddb5b53e3d.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/24jHQjBq5dXgXl.x.Slx1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4bb8b31b056b56472902a0ddb5b53e3d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-deck-152300057.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-deck-152300057.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T18:55:00+00:00",
    "headline": "Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings",
    "summary": "Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.",
    "url": "https://finance.yahoo.com/news/pharma-specialty-units-likely-drive-185500867.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d77f196b-caa9-3b66-87ac-66eb976d71d8",
      "content": {
        "id": "d77f196b-caa9-3b66-87ac-66eb976d71d8",
        "contentType": "STORY",
        "title": "Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings",
        "description": "",
        "summary": "Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.",
        "pubDate": "2026-02-04T18:55:00Z",
        "displayTime": "2026-02-04T18:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d7sHwZPFV1U3B4BGoNlXfg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k5CBlnqEqKxZI1S0BuG_ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharma-specialty-units-likely-drive-185500867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-specialty-units-likely-drive-185500867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]